Back

Validation of the BALLAR score for predicting 30-day mortality in patients requiring Impella monotherapy

27 August 2023 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Risk stratification in acute coronary syndromes with cardiogenic shock Shock ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Alexander Tindale

Harefield Hospital, Royal Brompton and Harefield NHS Foundation Trust, London (United Kingdom of Great Britain & Northern Ireland)

6 More presentations in this session

Presentation thumbnail
Predictive values of age shock index and age modified shock index for in-hospital mortality in patients with ST-segment elevation myocardial infarction
Miss S. Lyu (Beijing, CN)
Abstract Slides Video
Presentation thumbnail
The BE-ALIVE score: predicting 30-day mortality in patients presenting with acute coronary syndromes and cardiogenic shock
Doctor A. Tindale (London, GB)
Abstract Slides Video
Presentation thumbnail
Outcome of patients with cardiogenic shock in acute myocardial infarction treated with Impella CP and a standardized protocol
Doctor M. Sramko (Prague, CZ)
Abstract Slides Video
Presentation thumbnail
Novel risk score of mortality prediction for critical cardiogenic shock patients
Doctor M. Wang (Kaohsiung, TW)
Abstract Slides Video
Presentation thumbnail
Temporal trends in intra-aortic balloon pump use
Doctor B. Cohen (Petah Tikva, IL)
Abstract Slides Video

Access the full session

Session thumbnail
Risk stratification in acute coronary syndromes with cardiogenic shock

The Event

Event poster

ESC Congress 2023

27 August 2023 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Novel scoring system specific for patients treated with micro-axial percutaneous left ventricular assist device
thumbnail
Congress Presentation
Internal and external validation of a novel scoring system specific for patients treated with micro-axial percutaneous left ventricular assist device
thumbnail
Congress Presentation
Prediction of mortality and heart failure admission with the mitraScore after percutaneous mitral valve repair: an external validation study

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources